Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Tumor Pathway Activations Inhibited by Dovitinib
Interventions
DRUG

Dovitinib (TKI258)

Dovitinib (TKI) will be dosed on a flat scale of 500 mg on a 5 days on/2 days off dosing schedule.

Trial Locations (49)

21229

St. Agnes Hospital St. Agnes Hospital (2), Baltimore

22031

Virginia Cancer Specialists Virginia Cancer Specialists, Fairfax

27518

Waverly Hematology Oncology, Cary

29303

Gibbs Cancer Center & Research Institute Spartanburg Reg. Healthcare, Spartanburg

30060

NorthWest Georgia Oncology Centers NW Georgia Oncology, Marietta

30607

University Cancer & Blood Center, LLC, Athens

32256

Cancer Specialists of North Florida Cancer Specialists (2), Jacksonville

32796

Space Coast Medical Associates Space Coast Cancer Center, Titusville

32804

Florida Hospital Cancer Institute, Orlando

33021

Memorial Cancer Institute Memorial Healthcare System, Hollywod

35211

Alabama Oncology, Birmingham

37203

Sarah Cannon Research Institute Tennessee Oncology, Nashville

37404

Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga

38120

The West Clinic, Memphis

44195

Cleveland Clinic Foundation Cleveland Clinic (19), Cleveland

45242

Oncology Hematology Care, Inc. Oncology Hematology Care (2), Cincinnati

46202

Indiana University Indiana Univ. - Purdue Univ., Indianapolis

47905

Horizon Oncology Center Horizon Oncology Ctr., Lafayette

48109

University of Michigan Int. Medicine Oncology, Ann Arbor

53226

Aurora Research Institute, Milwaukee

Medical College of Wisconsin Cancer Ctr.-Froedtert Hospital, Milwaukee

55404

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology, Minneapolis

59107

Billings Clinic Onc Dept, Billings

60611

Lurie Children's Hospital of Chicago Developmental Therapeutics, Chicago

68510

Southeast Nebraska Oncology Cancer Center, Lincoln

72703

Highlands Oncology Group SC, Fayetteville

75246

Texas Oncology Texas Oncology - Sammons, Dallas

75251

Texas Oncology Midtown Texas Oncology, Dallas

75702

Tyler Cancer Center, Tyler

76104

The Center for Cancer and Blood Disorders, Fort Worth

77024

Oncology Consultants Oncology Group, Houston

77030

MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston

78759

Austin Cancer Centers Austin Cancer Center (2), Austin

84157

Intermountain Medical Center Intermountain Healthcare, Murray

89109

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2), Las Vegas

90403

Sarcoma Oncology Center, Santa Monica

93449

PCR Oncology, Pismo Beach

97239

Oregon Health & Science University OHSU Knight Cancer Institute, Portland

97701

St. Charles Cancer Center, Bend

98201

Providence Regional Cancer Partnership Providence Reg. Cancer (2), Everett

98405

Northwest Medical Specialties Hematology/Oncology, Tacoma

98801

Wenatchee Valley Medical Center Wenatchee Valley, Wenatchee

98902

Yakima Valley Memorial Hospital North Star Lodge Cancer Center, Yakima

99218

Evergreen Hematology & Oncology, Spokane

Unknown

Rocky Mountain Cancer Centers Rocky Mountain Cancer Centers, Greenwood Village

06856

Whittingham Cancer Center Norwalk Hospital, Norwalk

61615-7828

Illinois Cancer Care, Peoria

15232-1305

University of Pittsburgh Cancer Institute, Pittsburgh

02903

Rhode Island Hospital Rhode Island Hosp. (2), Providence

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY